Placebo effect in osteoarthritis: Why not use it to our advantage?

World Journal of Orthopedics

Volumn 6, Issue 5, 2015, Pages 416-420

  de Campos, Gustavo C ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Osteoarthritis; Placebo; Treatment

Indexed keywords

EID: 84930510761     PISSN: None     EISSN: 22185836     Source Type: Journal    
DOI: 10.5312/wjo.v6.i5.416     Document Type: Editorial

References (35)

1. Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, Gabriel S, Hirsch R, Hochberg MC, Hunder GG, Jordan JM, Katz JN, Kremers HM, Wolfe F. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008; 58: 26-35 [PMID: 18163497 DOI: 10.1002/art.23176]
2. Bitton R. The economic burden of osteoarthritis. Am J Manag Care 2009; 15: S230-S235 [PMID: 19817509]
3. de Rezende MU, de Campos GC, Pailo AF. Current concepts in osteoarthritis. Acta Ortop Bras 2013; 21: 120-122 [PMID: 24453655 DOI: 10.1590/S1413-78522013000200010]
4. Du S, Yuan C, Xiao X, Chu J, Qiu Y, Qian H. Self-management programs for chronic musculoskeletal pain conditions: a systematic review and meta-analysis. Patient Educ Couns 2011; 85: e299-e310 [PMID: 21458196 DOI: 10.1016/j.pec.2011.02.021]
5. Manheimer E, Cheng K, Linde K, Lao L, Yoo J, Wieland S, van der Windt DA, Berman BM, Bouter LM. Acupuncture for peripheral joint osteoarthritis. Cochrane Database Syst Rev 2010;(1): CD001977 [PMID: 20091527 DOI: 10.1002/14651858. CD001977.pub2]
6. Jansen MJ, Viechtbauer W, Lenssen AF, Hendriks EJ, de Bie RA. Strength training alone, exercise therapy alone, and exercise therapy with passive manual mobilisation each reduce pain and disability in people with knee osteoarthritis: a systematic review. J Physiother 2011; 57: 11-20 [PMID: 21402325 DOI: 10.1016/S1836-9553(11)70002-9]
7. McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, Hawker GA, Henrotin Y, Hunter DJ, Kawaguchi H, Kwoh K, Lohmander S, Rannou F, Roos EM, Underwood M. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 2014; 22: 363-388 [PMID: 24462672 DOI: 10.1016/j.joca.2014.01.003]
8. Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, Towheed T, Welch V, Wells G, Tugwell P. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012; 64: 465-474 [PMID: 22563589]
9. Coe R. It's the effect size, stupid: What effect size is and why it is important. 2002. Available from: URL: http://www.ttrb3.org.uk/itsthe-effect-size-stupid-what-effect-size-is-and-why-it-is-important/
10. Christensen R, Bartels EM, Astrup A, Bliddal H. Effect of weight reduction in obese patients diagnosed with knee osteoarthritis: a systematic review and meta-analysis. Ann Rheum Dis 2007; 66: 433-439 [PMID: 17204567 DOI: 10.1136/ard.2006.065904]
11. Towheed TE, Maxwell L, Judd MG, Catton M, Hochberg MC, Wells G. Acetaminophen for osteoarthritis. Cochrane Database Syst Rev 2006; (1): CD004257 [PMID: 16437479 DOI: 10.1002/14651858.CD004257.pub2]
12. Lee C, Hunsche E, Balshaw R, Kong SX, Schnitzer TJ. Need for common internal controls when assessing the relative efficacy of pharmacologic agents using a meta-analytic approach: case study of cyclooxygenase 2-selective inhibitors for the treatment of osteoarthritis. Arthritis Rheum 2005; 53: 510-518 [PMID: 16082648 DOI: 10.1002/art.21328]
13. de Campos GC, Rezende MU, Pailo AF, Frucchi R, Camargo OP. Adding triamcinolone improves viscosupplementation: a randomized clinical trial. Clin Orthop Relat Res 2013; 471: 613-620 [PMID: 23100188 DOI: 10.1007/s11999-012-2659-y]
14. Zhang W, Robertson J, Jones AC, Dieppe PA, Doherty M. The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials. Ann Rheum Dis 2008; 67: 1716-1723 [PMID: 18541604 DOI: 10.1136/ard.2008.092015]
15. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Biological, clinical, and ethical advances of placebo effects. Lancet 2010; 375: 686-695 [PMID: 20171404 DOI: 10.1016/S0140-6736(09)61706-2]
16. Kaptchuk TJ. Powerful placebo: the dark side of the randomised controlled trial. Lancet 1998; 351: 1722-1725 [PMID: 9734904 DOI: 10.1016/S0140-6736(97)10111-8]
17. Anon. The humble humbug. Lancet 1954; ii: 321
18. Doherty M, Dieppe P. The "placebo" response in osteoarthritis and its implications for clinical practice. Osteoarthritis Cartilage 2009; 17: 1255-1262 [PMID: 19410027 DOI: 10.1016/j.joca.2009.03.023]
19. Beecher HK. The powerful placebo. J Am Med Assoc 1955; 159: 1602-1606 [PMID: 13271123]
20. Abhishek A, Doherty M. Mechanisms of the placebo response in pain in osteoarthritis. Osteoarthritis Cartilage 2013; 21: 1229-1235 [PMID: 23973135 DOI: 10.1016/j.joca.2013.04.018]
21. Brody H. Placebos and the philosophy of medicine: Clinical, conceptual, and ethical issues. 1980. Available from: URL: http://www.amazon.com/Placebos-Philosophy-Medicine-Clinical-Conceptual/dp/0226075311
22. Hróbjartsson A, Gøtzsche PC. Is the placebo powerless? Update of a systematic review with 52 new randomized trials comparing placebo with no treatment. J Intern Med 2004; 256: 91-100 [PMID: 15257721 DOI: 10.1111/j.1365-2796.2004.01355.x]
23. Blackwell B, Bloomfield SS, Buncher CR. Demonstration to medical students of placebo responses and non-drug factors. Lancet 1972;1: 1279-1282 [PMID: 4113531]
24. Branthwaite A, Cooper P. Analgesic effects of branding in treatment of headaches. Br Med J (Clin Res Ed) 1981; 282: 1576-1578 [PMID: 6786566]
25. Waber RL, Shiv B, Carmon Z, Ariely D. Commercial features of placebo and therapeutic efficacy. JAMA 2008; 299: 1016-1017 [PMID: 18319411 DOI: 10.1001/jama.299.9.1016]
26. Kirsch I, Weixel LJ. Double-blind versus deceptive administration of a placebo. Behav Neurosci 1988; 102: 319-323 [PMID: 3365327]
27. Price DD, Milling LS, Kirsch I, Duff A, Montgomery GH, Nicholls SS. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain 1999; 83: 147-156 [PMID: 10534585]
28. Colloca L, Lopiano L, Lanotte M, Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurol 2004; 3: 679-684 [PMID: 15488461 DOI: 10.1016/S1474-4422(04)00908-1]
29. Suarez-Almazor ME, Looney C, Liu Y, Cox V, Pietz K, Marcus DM, Street RL. A randomized controlled trial of acupuncture for osteoarthritis of the knee: effects of patient-provider communication. Arthritis Care Res (Hoboken) 2010; 62: 1229-1236 [PMID: 20506122 DOI: 10.1002/acr.20225]
30. Weinberger M, Tierney WM, Booher P, Katz BP. Can the provision of information to patients with osteoarthritis improve functional status? A randomized, controlled trial. Arthritis Rheum 1989;32: 1577-1583 [PMID: 2688659]
31. Bannuru R, Schmid C, Sullivan M, Kent D, Wong J, McAlindon T. Differential response of placebo treatments in osteoarthritis trials: a systematic review and network meta-analysis. Osteoarthritis and Cartilage 2014; 22: S24-S25 [DOI: 10.1016/j.joca.2014.02.068]
32. Sihvonen R, Paavola M, Malmivaara A, Itälä A, Joukainen A, Nurmi H, Kalske J, Järvinen TL. Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear. N Engl J Med 2013; 369: 2515-2524 [PMID: 24369076 DOI: 10.1056/NEJMoa1305189]
33. Thomas KB. General practice consultations: is there any point in being positive? Br Med J (Clin Res Ed) 1987; 294: 1200-1202 [PMID: 3109581]
34. Campos GC, Rezende MU, Pasqualin T, Frucchi R, Bolliger Neto R. Lateral wedge insole for knee osteoarthritis: randomized clinical trial. Sao Paulo Med J 2015; 133: 13-19 [PMID: 25626851 DOI: 10.1590/1516-3180.2013.6750002]
35. Campos GC. Chondroprotective agents: are we being too dogmatic?. Medicalexpress 2014; 1: 211-213 [DOI: 10.5935/MedicalExpress.2014.04.10]